INSTRUCTIONS Over-the-counter medications and pregnancy: An integrative review
* To take the test online, go to our secure website at http://www.nursingcenter.com/ce/NP.
* On the print form, record your answers in the test answer section of the CE enrollment form on page 29. Each question has only one correct answer. You may make copies of these forms.
* Complete the registration information and course evaluation. Mail the completed form and registration fee of $24.95 to: Lippincott Williams & Wilkins, CE Group, 2710 Yorktowne Blvd., Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
* You will receive your CE certificate of earned -contact hours and an answer key to review your results.There is no minimum passing grade.
* Registration deadline is June 30, 2013.
DISCOUNTS and CUSTOMER SERVICE
* Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together and deduct $0.95 from the price of each test.
* We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Williams & Wilkins, publisher of The Nurse Practitioner journal, will award 2.5 contact hours for this continuing nursing education activity.
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.5 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454.
Your certificate is valid in all states. This activity has been assigned 2.5 pharmacology credits.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
Over-the-counter medications and pregnancy: An integrative review
General Purpose: To provide the NP with a review of OTC medications and their use during pregnancy. Learning Objectives: After reading the preceding article and taking the following test, you should be able to: 1. Describe the use of OTC medication during pregnancy. 2. Identify the FDA Risk Classifications in Pregnancy of specific medications. 3. Discuss the advantages and disadvantages of specific OTC medications in pregnancy.
1. The percentage of pregnant women who self-medicate with at least five OTC medications is more than
2. Which FDA Risk Classification indicates that the drug should be taken in pregnancy only if the potential benefit justifies the potential risk to the fetus?
a. Category A
b. Category B
c. Category C
d. Category D
3. Which pain medication is used by at least 65.5% of women at some point during their pregnancy?
4. According to Glover et al., as pregnancy progresses, the use of
a. acetaminophen decreases.
b. acetaminophen increases.
c. NSAIDs decreases.
d. NSAIDs increases.
5. Ibuprofen during pregnancy is classified as FDA category
6. Ibuprofen taken in the first trimester -increases risk of
a. renal anomalies.
c. neural tube defects.
d. congenital heart defects.
7. Aspirin full dose, when taken in the third trimester, is listed as FDA category
8. Which medication appears to be the best choice for both pain and fever reduction in pregnant women?
c. full-dose aspirin
d. low-dose aspirin
9. Which cold and allergy medication is -classified during pregnancy as FDA category B?
10. Which of the following statements about pseudoephedrine is correct?
a. Pseudoephedrine may increase maternal BP and decrease uterine blood flow
b. Approximately 80% of pregnant women take pseudoephedrine during pregnancy.
c. Pseudoephedrine is a potent vasodilator.
d. Pseudoephedrine has no effect on uterine blood flow.
11. The percentage of pregnant women who take some sort of cough medication is more than
12. Both dextromethorphan and guaifenesin are classified as FDA pregnancy category
13. About what percentage of pregnant women have common gastrointestinal complaints such as flatulence, heartburn, and constipation?
14. Which statement about simethicone is correct?
a. It is classified as FDA pregnancy category B.
b. The drug is not absorbed systemically, and considered safe for use in pregnancy.
c. Simethicone use during pregnancy is associated with cardiac defects.
d. It is the only antiflatulent that is systemically absorbed.
15. Kaolin may predispose pregnant women to
c. gestational diabetes.
d. iron deficiency anemia.
16. Docusate sodium is associated with which congenital defect?
b. congenital heart defect
c. neural tube defect
17. The first-line antacid drug choice during pregnancy should be
18. H2 receptor antagonists during pregnancy are classified as FDA category